The total synthesis of (À)-amidepsine B, a potent diacylglycerol acyltransferase inhibitor, has been achieved. This synthetic study resulted in the revision of the previously assigned stereostructure of the natural amidepsine B and determined the absolute configuration. Keywords: absolute configuration; (À)-amidepsine B; total synthesis INTRODUCTION Amidepsines A-E were isolated from the culture broth of fungal strains FO-2942 and FO-5969 and found to be inhibitors of diacylglycerol acyltransferase (DGAT), 1-3 which is exclusively involved in triacylglycerol formation. Excessive accumulation of triacylglycerol can cause fatty liver, obesity and hypertriglyceridemia, which leads to serious diseases, such as atherosclerosis, diabetes and metabolic disorders. Therefore, DGAT inhibitors have the potential to become drugs. Spectroscopic analyses of the amidepsines elucidated depsipeptide structures consisting of three 4,6-dihydroxy-2-methylbenzoic acid derivatives and an amino acid (except for amidepsine D), as shown in Figure 1 . The DGAT inhibitory activity of the amidepsines was tested by a cellular assay using Raji cells, and the results showed that amidepsine B (1) was the most potent inhibitor. Amidepsine B (1) was previously determined to be a mixture of stereoisomers at its single chiral center, the alanine alpha carbon. A 3:2 mixture of L-and D-alanines was revealed by acid hydrolysis followed by HPLC analyses using a chiral column (Amidepsines A and C were also reported as a 3:2 mixture of L-and D-amino acids 2 ). Herein, the total synthesis of amidepsine B and a revision of its absolute configuration will be described.
INTRODUCTION
Amidepsines A-E were isolated from the culture broth of fungal strains FO-2942 and FO-5969 and found to be inhibitors of diacylglycerol acyltransferase (DGAT), [1] [2] [3] which is exclusively involved in triacylglycerol formation. Excessive accumulation of triacylglycerol can cause fatty liver, obesity and hypertriglyceridemia, which leads to serious diseases, such as atherosclerosis, diabetes and metabolic disorders. Therefore, DGAT inhibitors have the potential to become drugs. Spectroscopic analyses of the amidepsines elucidated depsipeptide structures consisting of three 4,6-dihydroxy-2-methylbenzoic acid derivatives and an amino acid (except for amidepsine D), as shown in Figure 1 . The DGAT inhibitory activity of the amidepsines was tested by a cellular assay using Raji cells, and the results showed that amidepsine B (1) was the most potent inhibitor. Amidepsine B (1) was previously determined to be a mixture of stereoisomers at its single chiral center, the alanine alpha carbon. A 3:2 mixture of L-and D-alanines was revealed by acid hydrolysis followed by HPLC analyses using a chiral column (Amidepsines A and C were also reported as a 3:2 mixture of L-and D-amino acids 2 ). Herein, the total synthesis of amidepsine B and a revision of its absolute configuration will be described.
RESULTS AND DISCUSSION
The synthesis used a known aldehyde 2, which is a common starting material for the preparation of key substrates 5 and 10 (scheme 1). 4 Regioselective p-O-methylation (In this reaction, reactivity of the hydroxy group adjacent to the formyl group in 3 would be precluded by the formation of an intramolecular hydrogen bond. Similar reactivity was observed. 5 ) followed by benzylation gave 4 quantitatively, which was treated with NaClO 2 to afford carboxylic acid 5 quantitatively. Furthermore, similar conversion of 2 to 8, including the formation of a p-O-methoxymethyl ether instead of methylation, was also accomplished quantitatively. Esterification of 8 with allyl bromide followed by deprotection of the methoxymethyl ether afforded 10 quantitatively.
Next, the key substrates 5 and 10 were coupled by treatment with trifluoroacetic anhydride (TFAA) to give rise to 11 quantitatively. Deprotection of the allyl ester in the presence of a palladium catalyst gave carboxylic acid 12 in 98% yield.
Subsequent esterification of 12 with 10 was troublesome. Esterification conditions, such as TFAA, 1-[(3-dimethylamino)propyl]-3-ethylcarbodiimide/dimethylaminopyridine (DMAP) and benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (BOP)/ Et 3 N/DMAP led to a low yield of the desired product 14 with side products, such as the anhydride of 12. Therefore, we next focused on esterification through the acid fluoride. 6 Reaction of 12 with (diethylamino)sulfur trifluoride (DAST) proceeded in 89% yield to furnish the stable acid fluoride 13. Treatment of 13 with sodium alkoxide, derived from 10 and sodium hydride, was effected to give the desired allyl ester 14 quantitatively. The allyl ester was then deprotected under palladium-catalyzed conditions to afford 15 quantitatively.
Having constructed the depside 15, we next turned to condensation with L-alanine before preparing the 3:2 mixture of L-and D-alanines toward the total synthesis (scheme 2). Treatment of 15 with L-alanine benzyl ester in the presence of BOP and Et 3 N produced benzyl ester (+)-16 in 79% yield. Finally, global deprotection by hydrogenolysis completed the total synthesis of (À)-amidepsine B [(À) - We next analyzed the synthetic amidepsines (+)-1 and (À)-1 and the natural amidepsine B (1) with a chiral HPLC column. When the 1:1 mixture of the synthetic amidepsines (+)-1 and (À)-1 was injected onto the chiral HPLC system, each enantiomer was separated completely as shown in Figure 2a . Figures 2b and c show the HPLC analytical data of (+)-1 and (À)-1, respectively. Next, the natural amidepsine B (1) was also subjected to HPLC analysis and it was determined that the retention time was identical to that of (À)-amidepsine B [(À)-1] as shown in Figure 2d .
This result shows that the absolute configuration of amidepsine B is S, derived from L-alanine, and that the previous determination of the absolute configuration of amidepsine B was inaccurate. It is likely that the acid hydrolysis of amidepsine B must have led to the epimerization of the resulting alanine. It is highly likely that amidepsines A and C are also L-amino acids, which will be reported in due course.
In conclusion, we have achieved the total synthesis of amidepsine B. Moreover, we have revised the absolute configuration of natural amidepsine B. Extension of this chemistry to the synthesis of structural analogs of amidepsine B so that the structure-activity Total synthesis of amidepsine B T Nagamitsu et al relationships can be explored is currently under way and will be reported in due course.
EXPERIMENTAL PROCEDURE
Commercially available solvents were dried and distilled before use. Reactions were monitored by TLC using Merck F60 254 silica gel plates (0.25 mm). Spots were visualized with ultraviolet (UV) light (254 nm) and stained with phosphomolybdic acid. Flash column chromatography was performed on silica gel 60N (spherical, neutral, particle size 40-50 mm).
Preparative TLC was performed on Merck F60 254 silica gel plates (0.50 mm). The chiral HPLC system was comprised of a Daicel-CHIRALPAK IA column (0.46 cm fÂ25 cm), and a mobile phase of hexane/THF (tetrahydrofuran)/ TFAA (80:20:0.1) (Senshu HPLC system; 10 ml injection; UV, 254 nm; flow rate, 1.0 ml min À1 ). Melting points were determined on a Yanagimoto micro melting apparatus and uncorrected. Optical rotations were obtained with a JASCO DIP-1000 polarimeter. Mass spectra were recorded on a JEOL JMS-700 mass spectrometer. FT-IR spectra were recorded on a Horiba FT-710 spectrometer. 1 H-NMR spectra were recorded on a JEOL JNM-EX270 (270 MHz), MERCURY-300 (300 MHz) and UNITY-400 (400 MHz) spectrometers in CDCl 3 or DMSO- 
2-Hydroxy-4-methoxy-6-methylbenzaldehyde (3)
To a solution of 2,4-dihydroxy-6-methylbenzaldehyde (2) (0.56 g, 3.68 mmol) in acetone (36.8 ml), K 2 CO 3 (0.51 g, 3.68 mmol) and CH 3 I (3.44 ml, 55.2 mmol) were added. The reaction mixture was stirred for 2.5 h at room temperature, quenched with H 2 O and extracted with EtOAc. The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel with an eluent (20:1 hexanes/EtOAc) to give 3 (0.61 g, quant.) as a white powder; m.p. 
2-Benzyloxy-4-methoxy-6-methylbenzaldehyde (4)
To a solution of 3 (0.60 g, 3.64 mmol) in N,N-dimethylformamide (DMF) (18.2 ml), K 2 CO 3 (5.03 g, 36.4 mmol) and BnCl (6.29 ml, 56.4 mmol) were added at 0 1C. After stirring for 2.5 h at room temperature, the reaction was quenched with H 2 O and extracted with CH 2 Cl 2 . The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel with an eluent (20:1 to 10:1 hexanes/EtOAc) to give 4 (0.93 g, quant.) as a white powder; m.p. 
2-Benzyloxy-4-methoxy-6-methylbenzoic acid (5)
To a solution of 4 (0.16 g, 0.61 mmol) in t-BuOH/H 2 O (1:1) (6.2 ml) 2-methyl-2-butene (0.26 ml, 2.45 mmol), NaH 2 PO 4 Á2H 2 O (0.29 g, 1.84 mmol) and NaClO 2 (0.17 ml, 1.84 mmol) were added at 0 1C. The reaction mixture was stirred for 24 h at room temperature, diluted with H 2 O and extracted with CH 2 Cl 2 . The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel with an eluent 
2-Hydroxy-4-methyoxymethoxy-6-methylbenzaldehyde (6)
To a solution of 5 (0.56 g, 3.70 mmol) in CH 2 Cl 2 (37.0 ml) i-Pr 2 NEt (0.71 ml, 4.07 mmol) and chloromethyl methyl ether (MOMCl) (0.56 ml, 7.39 mmol) were added at 0 1C. After stirring for 45 min at room temperature, the reaction was quenched with H 2 O and extracted with CH 2 Cl 2 . The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel with an eluent (30:1 hexanes/EtOAc) to give 6 (0.72 g, quant.) as a white powder; m.p. 
2-Benzyloxy-4-hydroxy-6-methylbenzoic acid allyl ester (10)
To a solution of 9 (2.10 g, 6.13 mmol) in CH 3 OH (30.5 ml), 6 N HCl (30.5 ml) was added. After stirring for 30 min at 60 1C, the reaction mixture was neutralized with a saturated aqueous NaHCO 3 solution and extracted with CH 2 Cl 2 . The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel with an eluent (10:1 hexanes/EtOAc) to give 10 ( 
2-Benzyloxy-4-(2-benzyloxy-4-methoxy-6-methyl) benzoyloxy-6-methylbenzoic acid allyl ester (11)
To a solution of 5 (0.19 g, 0.69 mmol) and 10 (0.17 g, 0.57 mmol) in toluene (2.3 ml), TFAA (0.57 ml) was added. 2-Benzyloxy-4-(2-benzyloxy-4-methoxy-6-methyl) benzoyloxy-6-methylbenzoyl fluoride (13)
To a solution of 12 (0.03 g, 0.06 mmol) in Et 2 O/CH 2 Cl 2 (2:1) (0.9 ml) DAST (18.6 ml, 0.14 mmol) was added. The reaction mixture was stirred for 1. 2-Benzyloxy-4-[2-benzyloxy-4-(2-benzyloxy-4-methoxy-6-methyl) benzoyloxy-6-methyl]benzoyloxy-6-methylbenzoic acid allyl ester (14)
To a solution of 10 (22.0 mg, 0.07 mmol) in THF (0.5 ml), NaH (6.0 mg, 0.15 mmol) was added at 0 1C under N 2 . After stirring for 5 min at room temperature, a solution of 13 (26.0 mg, 0.05 mmol) in THF (0.5 ml) was added dropwise. After 30 min, the mixture was treated with MOMCl (3.8 ml, 0.05 mmol) for the conversion of an excess amount of 10 into 9 and then stirred for 30 min. A mixture of (+)-(16) (25.1 mg, 0.03 mmol) and Pd(OH) 2 (12.2 mg) in THF/EtOH (1:1) (2.8 ml) was stirred under H 2 atmosphere for 16 h. The mixture was filtered through a pad of Celite and the filtrate was concentrated. The residue was purified by preparative TLC on silica gel (5:1 CHCl 3 /CH 3 OH) with an eluent (3:1 CHCl 3 /CH 3 OH) to give (À)-(1) as a white powder (13.0 mg, 87%). Moreover, this sample was dissolved in CHCl 3 /CH 3 OH (25:1) (5 ml) and washed with 1% aqueous H 3 PO 4 (1 ml). The organic phase was dried over anhydrous Na 2 SO 4 and concentrated in vacuo to give (À)- (1) Total synthesis of amidepsine B T Nagamitsu et al
